Duration of checkpoint inhibitor therapy
17 May 2017
Duration of checkpoint inhibitor therapy
PD1/ CTLA4 : Upfront or sequentially?
Brain metastases: a role of conventional chemotherapy?
New imaging approaches for the diagnosis of melanoma and skin cancer
Deregulated TGF-β superfamily signalling in cancer
The potential of aspirin in the prevention and treatment of cancer
Functions of BRCA1 and the implications for treatment
Genetic determinants of breast cancer immune phenotypes
IMPAKT conference highlights
Mutational landscapes in pregnant and non-pregnant breast cancer
Resistance to CDK4/6 inhibitors
Deciphering the connection of genetics, immune infiltration and prognosis